Medacta Group SA (0A05.L)
| Previous close | 97.74 |
| Open | 97.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 96.30 - 97.70 |
| 52-week range | 96.30 - 97.70 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 1.938B |
| Beta (5Y monthly) | 1.30 |
| PE ratio (TTM) | 32.54 |
| EPS (TTM) | 2.97 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- EQS Group
Medacta Group SA reports 19.0% growth of half-year revenue
Medacta Group SA / Key word(s): Sales Result29-Jul-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Press Release – Ad-hoc announcement pursuant to Art. 53 LR Medacta Group SA reports 19.0% growth of half-year revenue 1H 2022 revenue increased to Euro 211.3 million, or 19.0% reported (14.6% at constant currency1) from 1H 2021 Significant customer acquisition, salesforce expansion and product introdu
- EQS Group
Medacta Announces First Lumbar Fusion Procedure with NextAR Augmented Reality Surgical Platform in Australia
Medacta Group SA / Key word(s): Product LaunchMedacta Announces First Lumbar Fusion Procedure with NextAR Augmented Reality Surgical Platform in Australia 23.06.2022 / 19:00 Media release Medacta Announces First Lumbar Fusion Procedure with NextAR Augmented Reality Surgical Platform in AustraliaCASTEL SAN PIETRO, Switzerland, 23 June 2022 – Medacta announces the first lumbar fusion procedure in Australia utilizing the M.U.S.T.® Pedicle Screw System in combination with NextARTM Spine, the first C
- Simply Wall St.
Shareholders in Mayne Pharma Group (ASX:MYX) are in the red if they invested five years ago
It is doubtless a positive to see that the Mayne Pharma Group Limited ( ASX:MYX ) share price has gained some 36% in...
